Cosette Pharmaceuticals Acquires Intrarosa from Endoceutics
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Jun 23
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
09 Jun 23
European champion committed to further extending global leadership in attractive and growing generics and biosimilars market, via purpose-driven…
08 Jun 23
Under the partnership, more than 1,700 IHC-validated antibodies from CST detected by fluorescent secondary antibodies will be used…
08 Jun 23
The partnership will start with Enterprise Search in Generative AI App Builder to enhance the efficiency of clinical…
08 Jun 23
Access to the industry's first Smart Care Facility Platform with Samsung Displays creates new opportunities for health systems…
08 Jun 23
The financing was led by new investor Norwest Venture Partners with participation from existing investors including Pitango Venture…
07 Jun 23
The US health regulator granted priority review for GSK’s sBLA and assigned a Prescription Drug User Fee Act…
06 Jun 23
UHG, through its health services unit Optum, has offered to pay $100 in cash per Amedisys share, which…
06 Jun 23
According to an interim analysis of the trial, the patients treated with Enhertu showed a confirmed ORR of…
06 Jun 23
The results revealed that a one-time treatment with Yescarta demonstrated significantly longer overall survival compared to SOC with…